These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24289821)

  • 1. Clinical and regulatory implications of active run-in phases in long-term studies for bipolar disorder.
    Cipriani A; Barbui C; Rendell J; Geddes JR
    Acta Psychiatr Scand; 2014 May; 129(5):328-42. PubMed ID: 24289821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.
    Cruz N; Sanchez-Moreno J; Torres F; Goikolea JM; Valentí M; Vieta E
    Int J Neuropsychopharmacol; 2010 Feb; 13(1):5-14. PubMed ID: 19638254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second generation antipsychotics in the treatment of bipolar depression: a systematic review and meta-analysis.
    De Fruyt J; Deschepper E; Audenaert K; Constant E; Floris M; Pitchot W; Sienaert P; Souery D; Claes S
    J Psychopharmacol; 2012 May; 26(5):603-17. PubMed ID: 21940761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrapyramidal adverse events associated with atypical antipsychotic treatment of bipolar disorder.
    Gentile S
    J Clin Psychopharmacol; 2007 Feb; 27(1):35-45. PubMed ID: 17224710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials.
    Scherk H; Pajonk FG; Leucht S
    Arch Gen Psychiatry; 2007 Apr; 64(4):442-55. PubMed ID: 17404121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aripiprazole for the maintenance treatment of bipolar I disorder: A review.
    McIntyre RS
    Clin Ther; 2010; 32 Suppl 1():S32-8. PubMed ID: 20152551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical antipsychotics and mood stabilization in bipolar disorder.
    Brambilla P; Barale F; Soares JC
    Psychopharmacology (Berl); 2003 Apr; 166(4):315-32. PubMed ID: 12607072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical usefulness of second-generation antipsychotics in treating children and adolescents diagnosed with bipolar or schizophrenic disorders.
    Gentile S
    Paediatr Drugs; 2011 Oct; 13(5):291-302. PubMed ID: 21888443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of bipolar disorder: the evolving role of atypical antipsychotics.
    Perlis RH
    Am J Manag Care; 2007 Nov; 13(7 Suppl):S178-88. PubMed ID: 18041879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons.
    Fraguas D; Correll CU; Merchán-Naranjo J; Rapado-Castro M; Parellada M; Moreno C; Arango C
    Eur Neuropsychopharmacol; 2011 Aug; 21(8):621-45. PubMed ID: 20702068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability of atypical antipsychotics in the treatment of adults with schizophrenia or bipolar disorder: a mixed treatment comparison of randomized controlled trials.
    Edwards SJ; Smith CJ
    Clin Ther; 2009 Jun; 31 Pt 1():1345-59. PubMed ID: 19698898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
    Jing Y; Kim E; You M; Pikalov A; Tran QV
    J Med Econ; 2009 Jun; 12(2):104-13. PubMed ID: 19527195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatments for acute bipolar depression: meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium and antipsychotics.
    Selle V; Schalkwijk S; Vázquez GH; Baldessarini RJ
    Pharmacopsychiatry; 2014 Mar; 47(2):43-52. PubMed ID: 24549862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotics as antidepressants.
    Roberts RJ; Lohano KK; El-Mallakh RS
    Asia Pac Psychiatry; 2016 Sep; 8(3):179-88. PubMed ID: 25963405
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.